Literature DB >> 7292210

Evaluation of the limulus amebocyte lysate assay for presumptive diagnosis of gonorrhea in men at a clinic for sexually transmitted diseases.

T A Chapel, M Adcock, B Smith, T Barnes, M Goodman.   

Abstract

Specimens of urethral exudate from 200 men with uncomplicated urethritis were tested for Neisseria gonorrhoeae by the limulus amebocyte lysate assay, culture on modified Thayer-Martin medium, and gram-stained smear. As compared with cultures, the sensitivity and specificity of the limulus assay were 94.8% and 89.3%, respectively, while the sensitivity and specificity of the gram stain were 98.8% and 100.0%, respectively. The accuracy of prediction of the presence of N. gonorrhoeae was significantly better by gram-stained smear than by the limulus assay. Unless the limulus assay is modified, as it was in this study, it does not appear to have a role in the presumptive diagnosis of the gonorrhea in men at a clinic for sexually transmitted diseases.

Entities:  

Mesh:

Year:  1981        PMID: 7292210     DOI: 10.1097/00007435-198107000-00001

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

Review 1.  Laboratory methods in genitourinary medicine. Methods of diagnosing gonorrhoea.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1990-12

2.  Lack of utility of a Limulus amoebocyte lysate assay in the diagnosis of urethral discharges in men.

Authors:  F N Judson; B A Werness; M R Shahan
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

3.  Improved utility of Gonoscreen, a Limulus amoebocyte lysate assay, in the evaluation of urethral discharges in men.

Authors:  R B Prior; V A Spagna
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

4.  Rapid evaluation of gonococcal and nongonococcal urethritis in men with Limulus amoebocyte lysate and a chromogenic substrate.

Authors:  R B Prior; V A Spagna
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.